Blog
RSS FeedPosted by Michael Wonder on 12 Nov 2019
'Incredibly upsetting': breast cancer patients dealing with shortage of common drug treatment
12 November 2019 - When Tricia Smith tried to fill her prescription for tamoxifen two weeks ago, she was shocked ...
Posted by Michael Wonder on 24 Oct 2019
Women living with metastatic breast cancer in British Columbia now have public access to Kisqali
23 October 2019 - Novartis Pharmaceuticals Canada is pleased to announce that British Columbia will now reimburse Kisqali (ribociclib) for eligible ...
Posted by Michael Wonder on 23 Sep 2019
Health‐related quality of life in oncology drug reimbursement submissions in Canada: a review of submissions to the pan‐Canadian Oncology Drug Review
23 September 2019 - In Canada, CADTH evaluates and makes recommendations for the reimbursement of cancer drugs. One component of ...
Posted by Michael Wonder on 20 Sep 2019
Addition of Kisqali to drug plan in Quebec expands access to treatment for metastatic breast cancer
19 September 2019 - Provincial reimbursement provides public access to treatment that may delay the progression of advanced breast cancer. ...
Posted by Michael Wonder on 13 Sep 2019
Medexus reports Health Quality Ontario recommends Gliolan for public reimbursement
12 September 2019 - Medexus Pharmaceuticals today announced that Health Quality Ontario, under the guidance of the Ontario Health Technology ...
Posted by Michael Wonder on 19 Aug 2019
Quebec becomes first province to list Lonsurf (trifluridine/tipiracil) for public reimbursement for adult patients with metastatic colorectal cancer
19 August 2019 - Cancer treatment taken orally shown to extend overall survival in patients whose disease has progressed following treatment ...
Posted by Michael Wonder on 06 Aug 2019
Cancer doctors are calling for a permanent fix to drug shortages in Canada
5 August 2019 - Three chemotherapy cancer drugs face national shortages, putting pressure on health care providers. ...
Posted by Michael Wonder on 12 Jun 2019
New drug helps extend survival rate of men with advanced prostate cancer: B.C. Cancer Agency study
10 June 2019 - At two years, advanced prostate cancer patients taking the trial drug, in addition to their standard treatment, ...
Posted by Michael Wonder on 23 Mar 2019
A patient’s journey with melanoma and drug coverage concerns
22 March 2019 - Living her best life with her husband Jeremy, Karen Formosa was looking forward to retiring within ...
Posted by Michael Wonder on 16 Dec 2018
2019 oncology drugs in pipeline — survey
14 December 2018 - pCODR is again undertaking its periodic survey to facilitate consistent and systematic data collection from participating ...
Posted by Michael Wonder on 05 Nov 2018
CADTH publishes initial recommendation for Tagrisso
5 November 2018 - CADTH has published its initial recommendation on the use of osimertinib mesylate for the first-line treatment ...
Posted by Michael Wonder on 05 Nov 2018
CADTH publishes initial recommendation for Lenvima
5 November 2018 - CADTH has published its initial recommendation on the use of lenvatinib mesylate in combination with everolimus ...
Posted by Michael Wonder on 17 Aug 2018
Hundreds of cancer patients received partial doses of medication
16 August 2018 - Hundreds of cancer patients in Canada did not receive the full dose of three highly concentrated ...
Posted by Michael Wonder on 21 Jun 2018
Whistler woman forced to fundraise for cancer drugs
21 June 2018 - Joni Denroche staying positive after insurance fails to cover needed treatment. ...
Posted by Michael Wonder on 04 Jun 2018
Same cancer, worse results and twice the cost in the US
1 June 2018 - Americans paid twice as much as Canadians for health care, but they didn't get twice the ...